Ligand News and Research

RSS
HBO treatments may improve neurological outcome after traumatic brain injury

HBO treatments may improve neurological outcome after traumatic brain injury

TargetEx to be the coordinator for CancerGrid consortium

TargetEx to be the coordinator for CancerGrid consortium

Membrane-bound Fas ligand is essential for cell death: Researchers

Membrane-bound Fas ligand is essential for cell death: Researchers

Ligand and GSK amend agreement to pursue independent research programs

Ligand and GSK amend agreement to pursue independent research programs

CEL-SCI Corporation engages a CRO for clinical trial of its investigational LEAPS-H1N1 treatment

CEL-SCI Corporation engages a CRO for clinical trial of its investigational LEAPS-H1N1 treatment

KemPharm announces nomination of its second pipeline candidate

KemPharm announces nomination of its second pipeline candidate

CEL-SCI to commence its LEAPS-H1N1 clinical trial following FDA approval

CEL-SCI to commence its LEAPS-H1N1 clinical trial following FDA approval

Small molecule blocks aberrant pathway associated with myotonic dystrophy

Small molecule blocks aberrant pathway associated with myotonic dystrophy

Iterative in situ click chemistry creates antibody-like protein-capture agents

Iterative in situ click chemistry creates antibody-like protein-capture agents

Phase I clinical trial data of GDC-0449 published in the New England Journal Of Medicine

Phase I clinical trial data of GDC-0449 published in the New England Journal Of Medicine

Cytrx’s study offers a better perception of arimoclomol's mechanism of action in induced animal stroke

Cytrx’s study offers a better perception of arimoclomol's mechanism of action in induced animal stroke

Tripep and Cosmix AG license RAS and mRNA Display Library technologies

Tripep and Cosmix AG license RAS and mRNA Display Library technologies

Neurogen stockholders to receive $11 million in Ligand Pharmaceuticals common stock as part of acquisition deal

Neurogen stockholders to receive $11 million in Ligand Pharmaceuticals common stock as part of acquisition deal

Results of PCF funded study could impact the standard of care for prostate cancer patients

Results of PCF funded study could impact the standard of care for prostate cancer patients

Shape-changing in proteins opens new avenue for drug discovery

Shape-changing in proteins opens new avenue for drug discovery

CEL-SCI expands work on current H1N1 virus vaccine

CEL-SCI expands work on current H1N1 virus vaccine

Discovery of gene associated with a three-fold increase in risk for testicular cancer

Discovery of gene associated with a three-fold increase in risk for testicular cancer

Adult stem cells from bone marrow can deliver cancer-killing proteins to tumors

Adult stem cells from bone marrow can deliver cancer-killing proteins to tumors

Determining success or failure in cholesterol-controlling drugs

Determining success or failure in cholesterol-controlling drugs

Lymphocytes promote cancer spread

Lymphocytes promote cancer spread